Laval M, Azou Y, Giorgi D, Rosset R
Exp Cell Res. 1986 Apr;163(2):381-95. doi: 10.1016/0014-4827(86)90069-8.
Drosophila cells were treated in vitro with N-phosphonacetyl-L-aspartate (PALA) which is a specific inhibitor of aspartate transcarbamylase, the second enzyme of the pyrimidine biosynthetic pathway. By stepwise selection using increasing amounts of this inhibitor, PALA-resistant (PALAr) stable clones have been isolated. Enzymatic activities of aspartate transcarbamylase, carbamyl phosphate synthetase and dihydro-orotase, borne by the same multifunctional protein, CAD, are increased 6-12-fold in these resistant clones compared with parental cells. The aspartate transcarbamylase in PALAr cells is shown by physical, kinetic and immunological criteria to be normal. The data from immunotitration and immunoblotting experiments indicate that the increased enzyme activities result from the overproduction of CAD.
用N-膦酰乙酰-L-天冬氨酸(PALA)对果蝇细胞进行体外处理,PALA是嘧啶生物合成途径中第二种酶——天冬氨酸转氨甲酰酶的特异性抑制剂。通过使用逐渐增加量的这种抑制剂进行逐步筛选,已分离出抗PALA(PALAr)稳定克隆。由同一多功能蛋白CAD承担的天冬氨酸转氨甲酰酶、氨甲酰磷酸合成酶和二氢乳清酸酶的酶活性,与亲代细胞相比,在这些抗性克隆中增加了6至12倍。根据物理、动力学和免疫学标准,PALAr细胞中的天冬氨酸转氨甲酰酶是正常的。免疫滴定和免疫印迹实验的数据表明,酶活性的增加是由于CAD的过量产生。